10/17/2024 3:54 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 15-12G | |
10/04/2024 3:21 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:24 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:27 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:30 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:33 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
|
10/04/2024 3:18 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form S-8 POS | |
10/04/2024 3:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form POSASR | |
08/27/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/15/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
08/13/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/07/2024 3:51 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
08/07/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/05/2024 7:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
08/01/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/31/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/30/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/29/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/25/2024 3:05 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 25 Notification of the removal from listing and registration of matured, redeemed or retired securities | |
07/18/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/18/2024 10:25 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:20 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
07/05/2024 5:48 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
07/05/2024 5:02 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
07/02/2024 9:18 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:41 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024 3:33 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC14D9C | |
06/20/2024 2:38 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-C | |
06/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D/A | |
06/10/2024 11:06 AM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 13G/A | |
06/10/2024 10:01 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2024 3:36 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2024 9:22 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
06/04/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 9:16 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/24/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 1:19 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/23/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 8:04 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 3:43 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
05/16/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/16/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 9:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/10/2024 9:31 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/08/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 3:45 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/07/2024 9:24 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/06/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/06/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/03/2024 9:29 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
05/02/2024 9:43 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2024 7:57 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 3:15 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/26/2024 9:11 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/25/2024 9:38 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 10:03 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2024 9:14 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 9:32 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 9:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024 3:31 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/18/2024 1:33 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC 13D | |
04/18/2024 9:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/17/2024 3:49 PM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9/A | |
04/17/2024 3:30 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 4:07 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/16/2024 9:12 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2024 2:44 PM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T/A | |
04/12/2024 9:54 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 10:57 AM | MorphoSys (Subject) MorphoSys AG (Subject)
| Form SC 14D9 | |
04/11/2024 5:01 AM | MorphoSys (Subject) MorphoSys AG (Subject) NOVARTIS AG (Filed by)
| Form SC TO-T | |
04/09/2024 9:07 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 9:19 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 9:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
04/02/2024 9:08 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2024 12:16 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 10:15 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 10:37 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 10:17 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/22/2024 5:47 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2024 10:27 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 3:12 PM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024 10:13 AM | MorphoSys (Filer) MorphoSys AG (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |